HK1178529A1 - 作為抗瘧疾劑的新型哌嗪類 - Google Patents
作為抗瘧疾劑的新型哌嗪類Info
- Publication number
- HK1178529A1 HK1178529A1 HK13105568.6A HK13105568A HK1178529A1 HK 1178529 A1 HK1178529 A1 HK 1178529A1 HK 13105568 A HK13105568 A HK 13105568A HK 1178529 A1 HK1178529 A1 HK 1178529A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- piperazines
- antimalarial agents
- antimalarial
- agents
- Prior art date
Links
- 239000003430 antimalarial agent Substances 0.000 title 1
- 150000004885 piperazines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IB2010050022 | 2010-01-05 | ||
| IB2010052045 | 2010-05-10 | ||
| PCT/IB2011/050009 WO2011083413A1 (en) | 2010-01-05 | 2011-01-04 | Piperazines as antimalarial agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1178529A1 true HK1178529A1 (zh) | 2013-09-13 |
Family
ID=43706300
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK13105568.6A HK1178529A1 (zh) | 2010-01-05 | 2013-05-09 | 作為抗瘧疾劑的新型哌嗪類 |
Country Status (27)
| Country | Link |
|---|---|
| EP (1) | EP2521715B1 (zh) |
| JP (1) | JP5165166B1 (zh) |
| KR (1) | KR101455484B1 (zh) |
| CN (1) | CN102666488B (zh) |
| AR (1) | AR079831A1 (zh) |
| AU (1) | AU2011204436B2 (zh) |
| BR (1) | BR112012016549A8 (zh) |
| CA (1) | CA2783882C (zh) |
| CL (1) | CL2012001641A1 (zh) |
| CY (1) | CY1115600T1 (zh) |
| DK (1) | DK2521715T3 (zh) |
| ES (1) | ES2523739T3 (zh) |
| HK (1) | HK1178529A1 (zh) |
| HR (1) | HRP20140890T1 (zh) |
| IL (1) | IL220698A (zh) |
| MA (1) | MA33979B1 (zh) |
| MX (1) | MX2012007172A (zh) |
| MY (1) | MY160904A (zh) |
| NZ (1) | NZ601607A (zh) |
| PL (1) | PL2521715T3 (zh) |
| PT (1) | PT2521715E (zh) |
| RU (1) | RU2555706C2 (zh) |
| SG (1) | SG181462A1 (zh) |
| SI (1) | SI2521715T1 (zh) |
| TW (1) | TWI402267B (zh) |
| WO (1) | WO2011083413A1 (zh) |
| ZA (1) | ZA201205879B (zh) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013018069A1 (en) | 2011-08-04 | 2013-02-07 | Actelion Pharmaceuticals Ltd | Combination of antimalarial agents |
| WO2014072903A1 (en) * | 2012-11-06 | 2014-05-15 | Actelion Pharmaceuticals Ltd | Novel aminomethyl-phenol derivatives as antimalarial agents |
| WO2014141175A1 (en) * | 2013-03-15 | 2014-09-18 | Actelion Pharmaceuticals Ltd | Novel acrylamide derivatives as antimalarial agents |
| JP2023510221A (ja) * | 2020-01-21 | 2023-03-13 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ヘテロ環化合物を含有する新規抗マラリア剤 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9910079D0 (en) | 1999-05-01 | 1999-06-30 | Smithkline Beecham Plc | Novel compounds |
| DE10008522A1 (de) * | 2000-02-24 | 2001-09-06 | Hassan Jomaa | Verwendung von 2-PHenylendiaminderivaten zur Behandlung von Infektionen |
| IL151923A0 (en) * | 2000-03-31 | 2003-04-10 | Pfizer Prod Inc | Novel piperazine derivatives |
| AR057836A1 (es) * | 2005-10-21 | 2007-12-19 | Actelion Pharmaceuticals Ltd | Piperizinas como agentes contra la malaria |
| CN101544630B (zh) * | 2009-05-13 | 2013-03-13 | 中国科学院广州生物医药与健康研究院 | 羟基化茚地那韦的制备方法 |
-
2011
- 2011-01-04 MX MX2012007172A patent/MX2012007172A/es active IP Right Grant
- 2011-01-04 MY MYPI2012003056A patent/MY160904A/en unknown
- 2011-01-04 JP JP2012547570A patent/JP5165166B1/ja not_active Expired - Fee Related
- 2011-01-04 BR BR112012016549A patent/BR112012016549A8/pt not_active Application Discontinuation
- 2011-01-04 TW TW100100230A patent/TWI402267B/zh not_active IP Right Cessation
- 2011-01-04 SI SI201130251T patent/SI2521715T1/sl unknown
- 2011-01-04 CN CN201180005082.3A patent/CN102666488B/zh active Active
- 2011-01-04 MA MA35112A patent/MA33979B1/fr unknown
- 2011-01-04 RU RU2012133265/04A patent/RU2555706C2/ru not_active IP Right Cessation
- 2011-01-04 PT PT117027029T patent/PT2521715E/pt unknown
- 2011-01-04 DK DK11702702.9T patent/DK2521715T3/da active
- 2011-01-04 SG SG2012040309A patent/SG181462A1/en unknown
- 2011-01-04 AR ARP110100014A patent/AR079831A1/es unknown
- 2011-01-04 NZ NZ601607A patent/NZ601607A/en not_active IP Right Cessation
- 2011-01-04 EP EP11702702.9A patent/EP2521715B1/en active Active
- 2011-01-04 CA CA2783882A patent/CA2783882C/en active Active
- 2011-01-04 AU AU2011204436A patent/AU2011204436B2/en not_active Ceased
- 2011-01-04 KR KR1020127020214A patent/KR101455484B1/ko active IP Right Grant
- 2011-01-04 ES ES11702702.9T patent/ES2523739T3/es active Active
- 2011-01-04 WO PCT/IB2011/050009 patent/WO2011083413A1/en active Application Filing
- 2011-01-04 PL PL11702702T patent/PL2521715T3/pl unknown
-
2012
- 2012-06-18 CL CL2012001641A patent/CL2012001641A1/es unknown
- 2012-07-01 IL IL220698A patent/IL220698A/en not_active IP Right Cessation
- 2012-08-03 ZA ZA2012/05879A patent/ZA201205879B/en unknown
-
2013
- 2013-05-09 HK HK13105568.6A patent/HK1178529A1/zh not_active IP Right Cessation
-
2014
- 2014-09-17 HR HRP20140890AT patent/HRP20140890T1/hr unknown
- 2014-09-24 CY CY20141100780T patent/CY1115600T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1175472A1 (zh) | 新型抗瘧疾試劑 | |
| EP2531061A4 (en) | TABLE | |
| EP2814472A4 (en) | DITHIOAMINE REDUCING AGENTS | |
| ZA201209251B (en) | Compositons | |
| GB201020076D0 (en) | Antimalarial compounds | |
| EP2643000A4 (en) | THERAPEUTIC PIPERAZINES | |
| AU335770S (en) | Sawhorse | |
| HK1178406A1 (zh) | 銷售架 | |
| HK1173368A1 (zh) | 色素沉着預防或改善劑 | |
| GB201111775D0 (en) | Compounds and uses thereof | |
| HK1178529A1 (zh) | 作為抗瘧疾劑的新型哌嗪類 | |
| EP2632916A4 (en) | NEW ANTICANCER AGENTS | |
| EP2564852A4 (en) | MEDICAMENT TREATING CEREBRAL TUMORS | |
| ZA201104164B (en) | Sulfamoyl-phenyl-ureido benzamidine-derivatives as antimalarial agents | |
| GB201012200D0 (en) | Trousers | |
| GB201112721D0 (en) | Antimalarial | |
| EP2640832A4 (en) | NEW ETHIOLOGICAL AGENT | |
| HUP1000034D0 (en) | Novel pharmaceutical agents | |
| AU4418P (en) | DrisStrawFifteen Fragaria xananassa | |
| AU4516P (en) | DrisStrawTwelve Fragaria xananassa | |
| GB201012370D0 (en) | Extending table | |
| TWM401351U (en) | Extension type table | |
| PL390851A1 (pl) | Blat stołu | |
| TWM390236U (en) | Spring-fixing base | |
| GB201012020D0 (en) | Payloaded stability |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20190104 |